middle.news
Alterity Therapeutics Secures Up to A$7.96 Million Through Underwritten ATHO Options
9:51am on Monday 31st of August, 2026 AEST
•
Biotechnology
Read Story
Alterity Therapeutics Secures Up to A$7.96 Million Through Underwritten ATHO Options
9:51am on Monday 31st of August, 2026 AEST
Key Points
Underwriter MST Financial Services to cover up to 8.4 million ATHO options
Potential capital raise between A$4.2 million and A$7.96 million before costs
Options expire 31 August 2026 at A$0.50 exercise price
Funds directed towards Phase 3 trial for ATH434 in Multiple System Atrophy
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Alterity Therapeutics (ASX:ATH)
OPEN ARTICLE